Intrinsic spectral imaging can visualize impressive details of small structures, allowing additional patients to be addressed, including those with heavy calcification or stents.
Low-dose spectral imaging can change the game in observing tumor development and metastases, supporting physicians in delivering better patient care.
Photon-counting CT can potentially scan sensitive patient groups without sedation and low dose without compromising image quality.
Improved image contrast and higher spatial resolution can increase confidence when assessing small anatomical details, even in small cerebral blood vessels.
Less image noise and inherent spectral information reduce radiation exposure for vulnerable patients with lung disease, without compromising image quality.
The new benchmark
The accelerator
The pioneer
Michael Brun Andersen, MD, PhD
Tilman Emrich, MD
Bari Dane, MD
Pál Maurovich-Horvat, MPH
Brian Ghoshhajra, MD, MBA, MSCCT